Cannabinoid Functions in Our Bodies
Your body produces its own cannabis-like molecules—endocannabinoids that help regulate sleep, appetite, pain, and memory every single day.
Science no longer asks whether cannabinoids interact with the human body; it asks how deeply they are woven into it. We are born with the endocannabinoid system (ECS), an internal signaling network, complete with its own cannabis-like molecules and receptors.
What began as a curiosity in the 1990s is now recognized as a central regulator of balance, or homeostasis, across multiple physiological systems.
Yet despite rapid scientific progress, cannabis research still faces regulatory friction, slowing what could be one of the most important frontiers in modern medicine.
What Is the Endocannabinoid System?
At its core, the ECS is a biological communication system that helps the body maintain internal stability.
It includes:
- Endocannabinoids (produced naturally by the body)
- Anandamide (AEA) – often called the “bliss molecule”
- 2-arachidonoylglycerol (2-AG) – a signaling lipid
- Receptors
- CB1 receptors – concentrated in the brain and central nervous system
- CB2 receptors – found mostly in immune cells and peripheral tissues
- Enzymes
- Responsible for synthesizing and breaking down endocannabinoids
When something shifts, such as pain, stress or inflammation, the ECS actively helps to bring the body back toward equilibrium.
Recent reviews, including pharmacology and neuroscience literature, confirm that the ECS plays a modulatory role across nearly all major organ systems, rather than acting in isolation.
How THC and CBD Interact With the Body
Cannabis-derived compounds, or phytocannabinoids, interact with this same system.
THC (Tetrahydrocannabinol)
- Directly activates CB1 receptors
- Influences mood, perception, appetite, and pain
- Responsible for the plant’s psychoactive effects
CBD (Cannabidiol)
- Does not strongly bind to CB1 receptors
- Modulates multiple pathways, including:
- Serotonin receptors (linked to anxiety and mood)
- TRPV1 receptors (involved in pain and inflammation)
A 2023 review in Frontiers in Pharmacology highlights that CBD’s effects are “multi-target”, explaining why its outcomes vary depending on dose, condition, and individual biology.
How the Cannabis Plant Produces Cannabinoids
The Cannabis plant manufactures cannabinoids using energy from the sun and nutrients from the soil—a simple summary of a highly efficient biosynthetic process.
The process begins with building blocks such as:
- Geranyl pyrophosphate (GPP) – a crucial 10-carbon intermediate
- Olivetolic acid (OA) – aromatic precursor
These combine to form CBGA (cannabigerolic acid), or the so-called “mother cannabinoid.”
From CBGA, enzyme-driven pathways produce:
- THCA → THC (via heat-induced decarboxylation)
- CBDA → CBD
- CBCA → CBC
Decarboxylation changes and amplifies the biological effects of these compounds by activating them.
Additional pathways produce:
- THCV (linked to metabolic effects)
- CBN (formed through THC degradation over time)
What the Endocannabinoid System Regulates
Novel research increasingly frames the ECS as a master regulator of homeostasis.
A 2022 review in Nature Reviews Neuroscience and subsequent clinical analyses substantiate ECS activity to:
- Pain signaling
- Mood and emotional regulation
- Sleep cycles
- Appetite and metabolism
- Immune response and inflammation
- Memory processing and stress adaptation
Rather than initiating these processes, the ECS fine-tunes their intensity and duration.
Appetite, Metabolism, and Energy Balance
Endocannabinoids play a direct role in hunger and energy regulation:
- Stimulate appetite via the hypothalamus
- Increase food palatability and reward
- Interact with key metabolic hormones:
- Ghrelin (hunger signal)
- Leptin (satiety hormone)
- Cholecystokinin (CCK) (signals fullness after eating)
A 2024 metabolic study validated that CB1 receptor activity is closely tied to energy storage and metabolic efficiency, helping explain THC’s appetite-stimulating effects.
Medical Applications: What the Evidence Supports
Pharmaceutical cannabinoids show where evidence is strongest:
- Dronabinol (Marinol)
- Synthetic THC
- Approved for chemotherapy-related nausea and appetite loss
- Nabiximols (Sativex)
- THC + CBD formulation
- Used for multiple sclerosis spasticity
Strongest evidence (supported by systematic reviews 2022–2024):
- Chronic pain (especially neuropathic pain)
- Chemotherapy-induced nausea and vomiting
- Multiple sclerosis-related spasticity
A 2023 meta-analysis in The BMJ and updated clinical reviews confirm moderate evidence of benefit in these areas, though effects vary by patient and formulation.
Cancer and Cannabinoids: What We Actually Know
Earlier claims in cannabis literature often overstated the science. Here’s the evidence-based position:
- Cannabinoids can:
- Induce apoptosis (cell death) in cancer cells in vitro
- Reduce tumor growth in some animal models
- However:
- There is no conclusive human evidence that cannabinoids cure or stop cancer
A 2022 oncology review concluded that cannabinoids may have adjunct potential, particularly for symptom relief (pain, nausea), but are not standalone cancer treatments.
Emerging Cannabinoids to Watch
THCV (Tetrahydrocannabivarin)
- May suppress appetite at certain doses
- Being studied for:
- Obesity
- Type 2 diabetes
- Early human trials (2022–2024) show metabolic effects without strong psychoactivity
CBC (Cannabichromene)
- Early-stage research suggests:
- Anti-inflammatory properties
- Potential neuroprotective effects
- Human data is still limited
The Bigger Picture: A System Built for Balance
Cannabinoids do not act like single-target drugs. They interact with a dynamic regulatory network embedded throughout the body.
That’s why their effects can feel so broad, and also why studying them remains complex.
The most accurate way to understand cannabinoids is not as miracle cures or simple recreational compounds, but as:
Biological modulators working within one of the body’s most important systems for maintaining balance.
A simple visual breakdown of how the endocannabinoid system regulates balance in the body—from mood and memory to pain and inflammation. Source: Carleton University via YouTube
Frequently Asked Questions about ECS and Cannabinoid Function
Q: What do cannabinoids do in the body?
A: They help regulate balance (homeostasis) by interacting with the endocannabinoid system.
Q: What is the endocannabinoid system (ECS)?
A: A biological network of receptors, molecules, and enzymes that maintains internal stability.
Q: What’s the difference between THC and CBD?
A: THC is psychoactive and binds to CB1 receptors, while CBD is non-intoxicating and works more indirectly.
Q: Does the human body produce cannabinoids?
A: Yes, it produces endocannabinoids like anandamide (AEA) and 2-AG.
Q: What are CB1 and CB2 receptors?
A: Part of the endocannabinoid system, CB1 receptors are mainly in the brain, while CB2 receptors are mostly in the immune system.
Q: Why does cannabis increase appetite?
A: THC activates CB1 receptors in the brain, enhancing hunger and food reward signals.
Q: Are cannabinoids medically useful?
A: Yes, they can help with chronic pain, nausea, multiple sclerosis-related symptoms, and a range of other health conditions.
Q: Can cannabinoids cure cancer?
A: No, but cannabinoids can significantly help manage various cancer-related symptoms.
Q: What is decarboxylation?
A: A process where heat converts inactive cannabinoids (like THCA) into active forms (like THC).
Q: What is the “entourage effect”?
A: The theory that cannabinoids and terpenes work better together than alone.
Q: Is CBD completely non-psychoactive?
A: CBD is non-intoxicating but can still affect mood and brain function.
Q: What does THCV do?
A: It may influence appetite and metabolism, but research is still ongoing.
Read more from Soft Secrets:
S
Soft Secrets
